A team of researchers will be extending the evaluation of the unique AVATAR therapy and assessing the feasibility of making it available in the NHS across the U [...]
Ten world-leading US, UK, and EU universities will discuss with leaders in national governments and funding bodies on how to harness the enormous potential of r [...]
UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technolog [...]
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, announced the closing of a $120 million extended [...]
LONDON – 25th June 2020 – UCL Business (UCLB) has won the Knowledge Exchange External Initiative of the Year in this year’s KE Awards organised by Praxis-Auril. [...]
Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a [...]
The biotechnology company focused on developing curative gene therapies for chronic systemic diseases has announced the appointment of Julie Krop M.D. as Chief [...]
Congratulations to Professor Bobby Gaspar of the UCL Great Ormond Street Institute of Child Health who has been named the new CEO of global gene therapy spinout [...]
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics Licens [...]
UCLB spinout companies Odin Vision and Echopoint Medical received awards at the 2019 SEHTA MedTech Business Awards on Thursday 6 February, alongside guest speak [...]
